Contineum Therapeutics, Inc. Class A Ownership | Who Owns Contineum Therapeutics, Inc. Class A?

Contineum Therapeutics, Inc. Class A Ownership Summary

Contineum Therapeutics, Inc. Class A is owned by 8.11% institutional investors, 1.10% insiders, and 90.78% retail investors. Ra capital management is the largest institutional shareholder, holding 8.19% of CTNM shares.

CTNM Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Contineum Therapeutics, Inc. Class A	8.11%	1.10%	90.78%
Sector	Healthcare Stocks	232.64%	10.66%	-143.30%
Industry	Biotech Stocks	382.13%	10.41%	-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ra capital management	2.12M	8.19%	$24.93M
Johnson & johnson	1.98M	7.04%	$22.62M
Franklin resources	1.88M	6.68%	$21.48M
Suvretta capital management	1.72M	6.64%	$20.21M
Vanguard group	1.27M	4.52%	$14.53M
Fmr	814.87K	3.15%	$9.57M
Sectoral asset management	800.79K	2.85%	$9.15M
Perceptive advisors	714.59K	2.76%	$8.40M
Hhlr advisors	669.34K	2.58%	$7.86M
Red tree management	638.16K	2.27%	$7.29M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Sectoral asset management	800.79K	7.34%	$9.15M
Red tree management	638.16K	6.69%	$7.29M
Versant venture management	542.63K	4.11%	$6.20M
Johnson & johnson	1.98M	4.08%	$22.62M
Monashee investment management	137.43K	0.89%	$1.57M
Samsara biocapital	571.14K	0.88%	$6.71M
Suvretta capital management	1.72M	0.52%	$20.21M
Silverarc capital management	307.54K	0.49%	$3.52M
Ra capital management	2.12M	0.31%	$24.93M
Perceptive advisors	714.59K	0.24%	$8.40M

Top Buyers

Holder	Shares	% Assets	Change
Ra capital management	2.12M	0.31%	2.12M
Vanguard group	1.27M	0.00%	306.63K
Franklin resources	1.88M	0.01%	223.82K
Blackrock funding, inc. /de	536.15K	0.00%	214.12K
Marshall wace, llp	193.49K	0.00%	164.81K

Top Sellers

Holder	Shares	% Assets	Change
Saturn v capital management	-	-	-319.35K
Stempoint capital lp	-	-	-265.83K
Baker bros. advisors lp	77.67K	0.01%	-234.83K
Adage capital partners gp	-	-	-200.00K
Schonfeld strategic advisors	18.50K	0.00%	-145.63K

New Positions

Holder	Shares	% Assets	Change	Value
Ra capital management	2.12M	0.31%	2.12M	$24.93M
Monashee investment management	137.43K	0.89%	137.43K	$1.57M
Eversept partners, lp	134.62K	0.11%	134.62K	$1.58M
Trexquant investment lp	29.31K	0.00%	29.31K	$344.39K
China universal asset management	3.76K	0.00%	3.76K	$43.02K

Sold Out

Holder	Change
Sbi securities	-1.00
Ifp advisors	-1.00
Srs capital advisors	-8.00
Advisor group	-10.00
Cubist systematic strategies	-24.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	10	-83.87%	2,281,353	-86.95%	8	0.18%	7	-77.42%	1	-94.74%
Sep 30, 2025	12	-82.86%	2,288,931	-83.48%	8	0.31%	7	-82.93%	3	-85.71%
Jun 30, 2025	69	13.11%	13,845,129	2.06%	53	1.94%	40	42.86%	21	16.67%
Mar 31, 2025	62	5.08%	15,117,518	-3.45%	58	0.89%	27	-30.77%	18	100.00%
Dec 31, 2024	60	17.65%	15,782,189	16.07%	81	2.92%	40	66.67%	9	-40.00%

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 02, 2026	Lorrain Daniel S.	Chief Scientific Officer	Sell	$62.59K
Mar 02, 2026	Watkins Tim	CMO & Head of Development	Sell	$54.22K
Feb 24, 2026	Stengone Carmine N.	CEO and President	Sell	$70.49K
Feb 25, 2026	Stengone Carmine N.	CEO and President	Sell	$43.24K
Feb 24, 2026	Lorrain Daniel S.	Chief Scientific Officer	Sell	$68.94K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	15
2025 Q4	-	2
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	3

CTNM Ownership FAQ

Who Owns Contineum Therapeutics, Inc. Class A?

Contineum Therapeutics, Inc. Class A shareholders are primarily institutional investors at 8.11%, followed by 1.10% insiders and 90.79% retail investors. The average institutional ownership in Contineum Therapeutics, Inc. Class A's industry, Biotech Stocks , is 382.13%, which Contineum Therapeutics, Inc. Class A falls below.

Who owns the most shares of Contineum Therapeutics, Inc. Class A?

Contineum Therapeutics, Inc. Class A’s largest shareholders are Ra capital management (2.12M shares, 8.19%), Johnson & johnson (1.98M shares, 7.04%), and Franklin resources (1.88M shares, 6.68%). Together, they hold 21.92% of Contineum Therapeutics, Inc. Class A’s total shares outstanding.

Does Blackrock own Contineum Therapeutics, Inc. Class A?

BlackRock is not among the top 10 institutional shareholders of Contineum Therapeutics, Inc. Class A.

Who is Contineum Therapeutics, Inc. Class A’s biggest shareholder by percentage of total assets invested?

Sectoral asset management is Contineum Therapeutics, Inc. Class A’s biggest shareholder by percentage of total assets invested, with 7.34% of its assets in 800.79K Contineum Therapeutics, Inc. Class A shares, valued at 9.15M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools